A
Ann M. Harper
Researcher at Tufts University
Publications - 56
Citations - 7074
Ann M. Harper is an academic researcher from Tufts University. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 29, co-authored 56 publications receiving 6505 citations. Previous affiliations of Ann M. Harper include Virginia Commonwealth University.
Papers
More filters
Journal ArticleDOI
Model for end-stage liver disease (MELD) and allocation of donor livers
Russell H. Wiesner,Erick B. Edwards,Richard B. Freeman,Ann M. Harper,Ray Kim,Patrick S. Kamath,Walter K. Kremers,John R. Lake,Todd K. Howard,Robert M. Merion,Robert A. Wolfe,Ruud A.F. Krom,Paul M. Colombani,Paige C. Cottingham,Stephen P. Dunn,John J. Fung,Douglas W. Hanto,Sue V. McDiarmid,John M. Rabkin,Lewis W. Teperman,Jeremiah G. Turcotte,Lynn Rothberg Wegman +21 more
TL;DR: Data suggest that the MELD score is able to accurately predict 3-month mortality among patients with chronic liver disease on the liver waiting list and can be applied for allocation of donor livers.
Journal ArticleDOI
The new liver allocation system: Moving toward evidence‐based transplantation policy
Richard B. Freeman,Russell H. Wiesner,Ann M. Harper,Sue V. McDiarmid,John R. Lake,Erick B. Edwards,Robert M. Merion,Robert Wolfe,Jeremiah G. Turcotte,Lewis W. Teperman +9 more
TL;DR: The development and initial implementation of a continuous disease severity scale that uses objective, readily available variables to predict mortality risk in patients with end‐stage liver disease and reduce the emphasis on waiting time is described.
Journal ArticleDOI
Results of the first year of the new liver allocation plan.
Richard B. Freeman,Russell H. Wiesner,Erick B. Edwards,Ann M. Harper,Robert M. Merion,Robert R. Wolfe +5 more
TL;DR: By eliminating the categorical waiting list prioritization system that emphasized time waiting, the new system has been associated with reduced registrations and improved transplantation rates without increased mortality rates for individual groups of waiting candidates or changes in early transplant survival rates.
Journal ArticleDOI
OPTN/SRTR 2016 Annual Data Report: Liver.
W. R. Kim,John R. Lake,Jodi M. Smith,David P. Schladt,Melissa Skeans,Ann M. Harper,J. L. Wainright,Jon J. Snyder,Ajay K. Israni,Bertram L. Kasiske +9 more
TL;DR: The number of pediatric living donor liver transplants decreased from a peak of 79 in 2015 to 62 in 2016, with most from donors closely related to the recipients.
Journal ArticleDOI
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.
Elizabeth A. Pomfret,Kenneth Washburn,Christoph Wald,Michael A. Nalesnik,David D. Douglas,Mark W. Russo,John P. Roberts,David J. Reich,Myron Schwartz,Luis Mieles,Fred T. Lee,Sander Florman,Francis Y. Yao,Ann M. Harper,Erick B. Edwards,Richard B. Freeman,John R. Lake +16 more
TL;DR: A national conference was held to better characterize the long‐term outcomes of liver transplantation for patients with hepatocellular carcinoma (HCC) and to assess whether it is justified to continue the policy of assigning increased priority for candidates with early‐stage HCC on the transplant waiting list in the United States.